JP2013544498A5 - - Google Patents

Info

Publication number

JP2013544498A5

JP2013544498A5 JP2013530291A JP2013530291A JP2013544498A5 JP 2013544498 A5 JP2013544498 A5 JP 2013544498A5 JP 2013530291 A JP2013530291 A JP 2013530291A JP 2013530291 A JP2013530291 A JP 2013530291A JP 2013544498 A5 JP2013544498 A5 JP 2013544498A5

Authority

JP

Japan

Prior art keywords

sequence

population

adapter

genomic

bound oligonucleotides

Prior art date

2011-09-21

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Granted

Links

• Espacenet
• Global Dossier
• Discuss

• 108091034117 Oligonucleotide Proteins 0.000 claims description 40
• 238000000034 method Methods 0.000 claims description 40
• 238000012163 sequencing technique Methods 0.000 claims description 29
• 108020004414 DNA Proteins 0.000 claims description 25
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 claims description 25
• 239000000758 substrate Substances 0.000 claims description 10
• 230000000295 complement effect Effects 0.000 claims description 9
• 150000007523 nucleic acids Chemical group 0.000 claims description 8
• 239000012634 fragment Substances 0.000 claims description 7
• 239000002773 nucleotide Substances 0.000 claims description 6
• 125000003729 nucleotide group Chemical group 0.000 claims description 6
• 238000013467 fragmentation Methods 0.000 claims description 5
• 238000006062 fragmentation reaction Methods 0.000 claims description 5
• FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 claims 2
• 238000011176 pooling Methods 0.000 claims 2
• 241000124008 Mammalia Species 0.000 claims 1
• 239000002299 complementary DNA Substances 0.000 claims 1
• 108091033319 polynucleotide Proteins 0.000 claims 1
• 102000040430 polynucleotide Human genes 0.000 claims 1
• 239000002157 polynucleotide Substances 0.000 claims 1
• 108091008146 restriction endonucleases Proteins 0.000 claims 1
• 238000010008 shearing Methods 0.000 claims 1
• 238000000527 sonication Methods 0.000 claims 1
• 239000000523 sample Substances 0.000 description 18
• 210000004027 cell Anatomy 0.000 description 11
• 239000007787 solid Substances 0.000 description 9
• 108700024394 Exon Proteins 0.000 description 6
• 238000003556 assay Methods 0.000 description 6
• 230000004048 modification Effects 0.000 description 6
• 238000012986 modification Methods 0.000 description 6
• 238000009396 hybridization Methods 0.000 description 5
• 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 4
• 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 4
• 238000006243 chemical reaction Methods 0.000 description 4
• 239000012530 fluid Substances 0.000 description 4
• 238000002360 preparation method Methods 0.000 description 4
• 238000012545 processing Methods 0.000 description 4
• 108700020796 Oncogene Proteins 0.000 description 3
• 230000003321 amplification Effects 0.000 description 3
• 238000013459 approach Methods 0.000 description 3
• 238000002474 experimental method Methods 0.000 description 3
• 238000003199 nucleic acid amplification method Methods 0.000 description 3
• 108090000623 proteins and genes Proteins 0.000 description 3
• 102000053602 DNA Human genes 0.000 description 2
• 102000043276 Oncogene Human genes 0.000 description 2
• 108020004682 Single-Stranded DNA Proteins 0.000 description 2
• 108020005202 Viral DNA Proteins 0.000 description 2
• 230000015572 biosynthetic process Effects 0.000 description 2
• 238000004925 denaturation Methods 0.000 description 2
• 230000036425 denaturation Effects 0.000 description 2
• 238000010438 heat treatment Methods 0.000 description 2
• 108020004707 nucleic acids Proteins 0.000 description 2
• 102000039446 nucleic acids Human genes 0.000 description 2
• 230000008569 process Effects 0.000 description 2
• 238000012360 testing method Methods 0.000 description 2
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
• 108020000946 Bacterial DNA Proteins 0.000 description 1
• 108091033380 Coding strand Proteins 0.000 description 1
• 230000007067 DNA methylation Effects 0.000 description 1
• 229920001213 Polysorbate 20 Polymers 0.000 description 1
• 108091023045 Untranslated Region Proteins 0.000 description 1
• 108020000999 Viral RNA Proteins 0.000 description 1
• 238000004458 analytical method Methods 0.000 description 1
• 238000000137 annealing Methods 0.000 description 1
• 230000001580 bacterial effect Effects 0.000 description 1
• 239000003153 chemical reaction reagent Substances 0.000 description 1
• 230000009089 cytolysis Effects 0.000 description 1
• 230000001419 dependent effect Effects 0.000 description 1
• 238000013461 design Methods 0.000 description 1
• 230000001973 epigenetic effect Effects 0.000 description 1
• 238000000605 extraction Methods 0.000 description 1
• 238000005194 fractionation Methods 0.000 description 1
• 230000002538 fungal effect Effects 0.000 description 1
• 238000001502 gel electrophoresis Methods 0.000 description 1
• 230000014509 gene expression Effects 0.000 description 1
• 230000002068 genetic effect Effects 0.000 description 1
• 238000011534 incubation Methods 0.000 description 1
• 230000010354 integration Effects 0.000 description 1
• 238000004519 manufacturing process Methods 0.000 description 1
• 239000000463 material Substances 0.000 description 1
• 108091070501 miRNA Proteins 0.000 description 1
• 239000002679 microRNA Substances 0.000 description 1
• 238000002493 microarray Methods 0.000 description 1
• 230000000813 microbial effect Effects 0.000 description 1
• 239000000203 mixture Substances 0.000 description 1
• 230000008520 organization Effects 0.000 description 1
• 230000007170 pathology Effects 0.000 description 1
• 229920002401 polyacrylamide Polymers 0.000 description 1
• 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
• 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
• 238000000746 purification Methods 0.000 description 1
• 230000008707 rearrangement Effects 0.000 description 1
• 230000003252 repetitive effect Effects 0.000 description 1
• 239000007790 solid phase Substances 0.000 description 1
• 238000003786 synthesis reaction Methods 0.000 description 1
• 230000008685 targeting Effects 0.000 description 1